SCHEMBL290358

SCHEMBL290358

CC=CCCc1cccc(CC(=O)OC)c1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 1/20 0.51
CYP4F2 P78329 3/20 0.46
CYP4A11 Q02928 3/20 0.46
ALDH1A1 P00352 2/20 0.43
GAA P10253 1/20 0.43
GFER P55789 1/20 0.43
HSP90AB1 P08238 1/20 0.42
KDM4E B2RXH2 1/20 0.42
LMNA P02545 1/20 0.42
GPR52 Q9Y2T5 4/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
TSHR P16473 1/20 0.41
TLR7 Q9NYK1 2/20 0.39
SIRT2 Q8IXJ6 1/20 0.39
MTNR1A P48039 1/20 0.39
MTNR1B P49286 1/20 0.39
KMT2A Q03164 1/20 0.39
AKT1 P31749 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1628157 1.00 SLC7A5 (0.51) SLC7A5CYP4F2CYP4A11ALDH1A1GAA
SCHEMBL290357 1.00 SLC7A5 (0.51) SLC7A5CYP4F2CYP4A11ALDH1A1GAA
SCHEMBL20259161 0.89 SLC7A5 (0.40) SLC7A5CYP4F2CYP4A11ALDH1A1KDM4E
SCHEMBL11892098 0.87 SLC7A5 (0.41) SLC7A5CYP4F2CYP4A11GPR52
SCHEMBL290033 0.85 SLC7A5 (0.54) SLC7A5CYP4F2CYP4A11ALDH1A1GAA
SCHEMBL4394735 0.84 SLC7A5 (0.62) SLC7A5CYP4F2CYP4A11ALDH1A1GAA
SCHEMBL289960 0.83 AKR1B1 (0.46) GAAKDM4ELMNAGPR52MAPT
SCHEMBL289958 0.83 AKR1B1 (0.46) GAAKDM4ELMNAGPR52MAPT
SCHEMBL28655132 0.83 SLC7A5 (0.57) SLC7A5CYP4F2CYP4A11ALDH1A1GAA
SCHEMBL12400239 0.82 SLC7A5 (0.68) SLC7A5CYP4F2CYP4A11ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2632452-A1 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CANCER ProMetic BioSciences Inc. (CA) 2013-09-04 EP disclosed
WO-2012097427-A1 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CANCER PROMETIC BIOSCIENCES INC. (CA) 2012-07-26 WO disclosed
EP-2427416-A1 SUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF ProMetic BioSciences Inc. (CA) 2012-03-14 EP disclosed
WO-2010127440-A1 SUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF PROMETIC BIOSCIENCES INC. (CA) 2010-11-11 WO disclosed